English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/16146
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 21 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors

AutorDolado, Ignacio; Nieto, Joan; Saraiva, Maria João; Arsequell, Gemma; Valencia Parera, Gregorio; Planas, Antoni
Palabras claveKinetic assay
In vitro inhibitors
hTTR Amyloid Fibril
High-Throughput Screening
Fecha de publicación10-feb-2005
EditorAmerican Chemical Society
CitaciónJournal of Combinatorial Chemistry 7(2): 246-252 (2005)
ResumenStabilization of tetrameric transthyretin (TTR) by binding of small ligands is a current strategy aimed at inhibiting amyloid fibrillogenesis in transthyretin-associated pathologies, such as senile systemic amyloidosis (SSA) and familial amyloidotic polyneuropathy (FAP). A kinetic assay is developed for rapid evaluation of compounds as potential in vitro inhibitors in a high-throughput screening format. It is based on monitoring the time-dependent increase of absorbance due to turbidity occurring by acid-induced protein aggregation. The method uses the highly amyloidogenic Y78F mutant of human transthyretin (heterogously expressed in Escherichia coli cells). Initial rates of protein aggregation at different inhibitor concentrations follow a monoexponential dose−response curve from which inhibition parameters are calculated. For the assay development, thyroid hormones and nonsteroidal antiinflamatory drugs were chosen among other reference compounds. Some of them are already known to be in vitro inhibitors of TTR amyloidogenesis. Analysis time is optimized to last 1.5 h, and the method is implemented in microtiter plates for screening of libraries of potential fibrillogenesis inhibitors.
Descripción7 pages, 4 figures, 1 scheme, 2 tables.-- PMID: 15762752 [PubMed].-- Printed version published Mar 2005.
Versión del editorhttp://dx.doi.org/10.1021/cc049849s
URIhttp://hdl.handle.net/10261/16146
DOI10.1021/cc049849s
ISSN1520-4766 (Print)
1520-4774 (Online)
Aparece en las colecciones: (IQAC) Artículos
Ficheros en este ítem:
No hay ficheros asociados a este ítem.
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.